Public plans covered only 26% of the 491 new drugs approved by Health Canada from 2009 to 2018; national pharmacare is an empty promise for 23.2 million Canadians now covered by private plans
September 11, 2019 09:00 ET
|
Canadian Health Policy Institute Inc.
TORONTO, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Two new studies confirm the abysmal state of access to innovative medicines in Canada’s publicly funded drug plans. The research, published in the journal...